{
    "Trade/Device Name(s)": [
        "TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge",
        "TEG 6s Hemostasis System"
    ],
    "Submitter Information": "Haemonetics Corporation",
    "510(k) Number": "K243858",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150041"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "January 15, 2025",
    "Summary Letter Received Date": "December 16, 2024",
    "Submission Date": "January 14, 2025",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose System For In Vitro Coagulation Studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Clotting Time (R)",
        "Speed of Clot Formation (K)",
        "Alpha angle",
        "Maximum Clot Strength (MA)",
        "Estimated Functional Fibrinogen Level (FLEV)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "TEG 6s Hemostasis analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Thromboelastography",
        "Optical detection of meniscus motion",
        "Resonance frequency measurement"
    ],
    "Methodologies": [
        "Semi-quantitative clot elasticity measurement",
        "Microfluidics-based cartridge assay"
    ],
    "Submission Type(s)": [
        "Assay Cartridge",
        "Analyzer",
        "System",
        "Software",
        "Reagent",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for the TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge for semi-quantitative analysis of hemostasis in citrated whole blood using thromboelastography",
    "Indications for Use Summary": "Intended for in vitro diagnostic use to provide semi-quantitative indications of the hemostasis state of adult venous blood samples using CK, CKH, CRT, and CFF assays, aiding evaluation of hemorrhage or thrombosis before, during, and after cardiovascular surgery or cardiology procedures; usable in laboratory and point-of-care settings",
    "fda_folder": "Hematology"
}